Related Experiment Video
Updated: Jun 25, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
The Evolving Epidemiology of Invasive Pneumococcal Disease in Australian Children: A Multicentre Retrospective
Phoebe C M Williams1,2,3,4, Annaleise Howard Jones1,5, Robert Duguid2
1Sydney Institute for Infectious Diseases, School of Public Health, Faculty of Medicine, University of Sydney, Sydney, NSW, Australia.
Insights
Nonpharmaceutical interventions during the COVID-19 pandemic altered invasive pneumococcal disease (IPD) in Australian children. Postpandemic, IPD cases showed increased meningitis and viral infections, suggesting a need for updated immunization strategies.
Area of Science:
- Pediatric Infectious Diseases
- Epidemiology
- Vaccinology
Background:
- Invasive pneumococcal disease (IPD) remains a significant public health concern in Australia despite high pneumococcal conjugate vaccine (PCV) coverage.
- The COVID-19 pandemic and associated nonpharmaceutical interventions (NPIs) potentially impacted IPD epidemiology and clinical presentation.
Purpose of the Study:
- To analyze the effect of NPIs on the clinical characteristics of IPD in Australian children.
- To compare IPD cases before and after the implementation of COVID-19 mitigation strategies.
Main Methods:
- Systematic evaluation of clinical and microbiological data of pediatric IPD cases (<18 years).
- Comparison of cases from two periods: 2017-2018 (prepandemic) and 2021-2022 (postpandemic).
- Analysis of case counts and proportions to identify changes in clinical presentations.
Main Results:
- A total of 220 IPD cases were identified; 116 prepandemic and 104 postpandemic.
- Serotype 3 was the most frequent causative agent (26%).
- Postpandemic cases exhibited a higher incidence of meningitis (13.5% vs 3.4%) and viral co-infections (63.8% vs 36.2%), with viral co-infections linked to prolonged fevers.
Conclusions:
- Changes in respiratory viral transmission patterns influence IPD epidemiology and clinical outcomes.
- Consideration of newer PCVs and immunization programs targeting associated viral pathogens may help reduce the burden of pediatric IPD.
Background:
In Australia, high pneumococcal conjugate vaccine (PCV) coverage has been achieved, yet invasive pneumococcal disease (IPD) continues to cause a significant burden of disease. The epidemiology of IPD was altered by the nonpharmaceutical interventions (NPIs) used to control the coronavirus disease (COVID-19) pandemic. We aimed to analyze this impact on the clinical characteristics associated with IPD in Australian children.
Method:
We systematically evaluated the clinical and microbiological characteristics of IPD in children (<18 years) presenting to 4 Australian children's hospitals 2 years before (2017-2018: prepandemic) and after (2021-2022: postpandemic) the implementation of NPIs to mitigate COVID-19. Case counts and proportions were used to compare clinical presentations.
Results:
We identified 220 cases of IPD: 116 in 2017-2018 and 104 in 2021-2022. Causative serotypes were available for 176 cases (80%), with serotype 3 most frequently identified (26% of serotyped IPD, 46/176). One-quarter of cases were due to serotypes included in newer PCVs. Postpandemic cases had a higher proportion of meningitis (13.5% vs 3.4%, P = .001) and test-confirmed associated viral infections (63.8% vs 36.2%, P = .008) compared to prepandemic cases. Children with viral co-infections were significantly more likely to have prolonged fevers (>14 days; 13% vs 1%, P = .001).
Conclusions:
Alternations in the prevalence of respiratory viral transmission influence the epidemiology and clinical presentation of IPD. Newer PCVs and the implementation of immunization programs that target viral pathogens associated with IPD may reduce the ongoing burden of IPD in children.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Respiratory Syncytial Virus Disease
Atypical Pneumonia

